Mark G. Saulnier

2.8k citations

49 papers · 1.7k indexed · h-index 21

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 7
Organic Chemistry top 2%
- Chemical synthesis and alkaloids 7
- Synthesis of heterocyclic compounds 6
- Advanced Synthetic Organic Chemistry 4
- Asymmetric Synthesis and Catalysis 4
Molecular Biology top 10%
- Cancer therapeutics and mechanisms 14
Biotechnology top 10%
Pharmaceutical Science top 5%
Endocrinology, Diabetes and Metabolism
- Growth Hormone and Insulin-like Growth Factors 5
Oncology
- Cancer Treatment and Pharmacology 5

Co-authors: Gordon W. Gribble David B. Frennesson Mukund P. Sibi Dolatrai M. Vyas Peter D. Senter Ingegerd Hellström George J. Schreiber Joseph P. Brown
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (2 papers)Biochemistry (1 paper)
Partner nations: United States Germany

In The Last Decade

Mark G. Saulnier

47 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mark G. Saulnier

Since Specialization

Citations

This map shows the geographic impact of Mark G. Saulnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Saulnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Saulnier more than expected).

Fields of papers citing papers by Mark G. Saulnier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Saulnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Saulnier. The network helps show where Mark G. Saulnier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark G. Saulnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark G. Saulnier Line = papers co-authored together Mark G. Saulnier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	5-Bromo-2-chloro-4-fluoro-3-iodopyridine as a Halogen-rich Intermediate for the Synthesis of Pentasubstituted Pyridines The Journal of Organic Chemistry ·Yong‐Jin Wu,Gerard J. Porter,David B. Frennesson,Mark G. Saulnier	2022	4
2	The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer Bioorganic & Medicinal Chemistry Letters ·Chetan Padmakar Darne,Upender Velaparthi,Mark G. Saulnier,David B. Frennesson,Peiying Liu,Audris Huang,John S. Tokarski,Aberra Fura,Thomas Spires,John A. Newitt,Vanessa Spires,Mary T. Obermeier,Paul A. Elzinga,Marco M. Gottardis,Lata Jayaraman,Gregory D. Vite,Aaron Balog	2022	7
3	SNAr reactions of 5-bromo-2-chloro-4-fluoro-3-iodopyridine and its 3-substituted analogs Tetrahedron Letters ·Gerard J. Porter,Mark G. Saulnier,Yong‐Jin Wu	2022	1
4	Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one Bioorganic & Medicinal Chemistry Letters ·Upender Velaparthi,Mark G. Saulnier,Mark D. Wittman,Peiying Liu,David B. Frennesson,Kurt Zimmermann,Joan M. Carboni,Marco M. Gottardis,Aixin Li,Ann Greer,Wendy Clarke,Zheng Yang,Krista Menard,Francis Y. Lee,George L. Trainor,Dolatrai M. Vyas	2010	16
5	2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 Bioorganic & Medicinal Chemistry Letters ·Mark G. Saulnier,David B. Frennesson,Mark D. Wittman,Kurt Zimmermann,Upender Velaparthi,David R. Langley,Charles Struzynski,Xiaopeng Sang,Joan M. Carboni,Aixin Li,Ann Greer,Zheng Yang,Praveen Balimane,Marco M. Gottardis,Ricardo M. Attar,Dolatrai M. Vyas	2008	20
6	Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors Bioorganic & Medicinal Chemistry Letters ·Kurt Zimmermann,Mark D. Wittman,Mark G. Saulnier,Upender Velaparthi,David R. Langley,Xiaopeng Sang,David B. Frennesson,Joan M. Carboni,Aixin Li,Ann Greer,Marco M. Gottardis,Ricardo M. Attar,Zheng Yang,Praveen Balimane,Lorell Discenza,Dolatrai M. Vyas	2008	17
7	BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in cancer cell lines Cancer Research ·Paul Haluska,Joan M. Carboni,David A. Loegering,Francis Y. Lee,Mark G. Saulnier,David B. Frennesson,Ricardo M. Attar,Kimberly R. Kalli,Cheryl A. Conover,Sumithra J. Mandrekar,Scott H. Kaufmann,Marco M. Gottardis,Charles Erlichman	2005	2
8	Quantitation of the Interaction of the Immunosuppressant Deoxyspergualin and Analogs with Hsc70 and Hsp90 Biochemistry ·Kari C. Nadeau,Steven G. Nadler,Mark G. Saulnier,Christopher T. Walsh,Mark A. Tepper	1994	98
9	An efficient method for the synthesis of guanidino prodrugs Bioorganic & Medicinal Chemistry Letters ·Mark G. Saulnier,David B. Frennesson,Milind Deshpande,Steven Hansel,Dolatrai M. Vyas	1994	7
10	ChemInform Abstract: Regioselective ortho‐Lithiation of Halopyridines. Synthesis of ortho‐ Disubstituted Pyridines and a Convenient Generation of 3,4‐Pyridyne. ChemInform ·Gordon W. Gribble,Mark G. Saulnier	1993	0
11	Regioselective ortho-Lithiation of Halopyridines. Syntheses of ortho-Disubstituted Pyridines and a Convenient Generations of 3,4-Pyridyne Heterocycles ·Gordon W. Gribble,Mark G. Saulnier	1993	51
12	Syntheses and Diels-Alder cycloaddition reactions of 4H-furo[3,4-b]indoles. A regiospecific Diels-Alder synthesis of ellipticine The Journal of Organic Chemistry ·Gordon W. Gribble,Daniel J. Keavy,Deborah A. Davis,Mark G. Saulnier,Benjamin Pelcman,Timothy C. Barden,Mukund P. Sibi,Erik R. Olson,Joseph J. BelBruno	1992	67
13	Synthesis of biological evaluation of 4′-deshydroxy-4′-methyl etoposide and teniposide analogs Bioorganic & Medicinal Chemistry Letters ·Mark G. Saulnier,Karen L. LeBoulleuc,Byron H. Long,Dolatrai M. Vyas,Alfred R. Crosswell,Terrence W. Doyle	1992	5
14	SYNTHESES OF 2,3-DIHALO-1-(PHENYLSULFONYL)INDOLES Organic Preparations and Procedures International ·Gordon W. Gribble,Brett D. Allison,Samuel C. Conway,Mark G. Saulnier	1992	4
15	Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30 Investigational New Drugs ·William C. Rose,George A. Basler,Pamela A. Trail,Mark G. Saulnier,Alfred R. Crosswell,Anna Maria Casazza	1990	19
16	ChemInform Abstract: Convergent Approach to Intermediates Used for the Synthesis of the Enediyne Structure of the Esperamicins and Calicheamicins. ChemInform ·John F. Kadow,Mark G. Saulnier,Min Min Tun,David R. Langley,Dolatrai M. Vyas	1990	1
17	E-ring desoxy analogs of etoposide Journal of Medicinal Chemistry ·Mark G. Saulnier,Dolatrai M. Vyas,David R. Langley,Terrence W. Doyle,William C. Rose,Alfred R. Crosswell,Byron H. Long	1989	26
18	ChemInform Abstract: SYNTHESES OF ELLIPTICINE AND RELATED PYRIDOCARBAZOLE ALKALOIDS ‐ A REVIEW Chemischer Informationsdienst ·G. W. GRIBBLE,Mark G. Saulnier	1985	49
19	Synthesis of 17-oxoellipticine Tetrahedron Letters ·Mark G. Saulnier,Gordon W. Gribble	1983	8
20	An efficient synthesis of ellipticine The Journal of Organic Chemistry ·Mark G. Saulnier,Gordon W. Gribble	1982	33

About Mark G. Saulnier

Mark G. Saulnier is a scholar working on Toxicology, Organic Chemistry and Pharmacology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), Bioactive Compounds and Antitumor Agents (7 papers), Chemical synthesis and alkaloids (7 papers), Synthesis of heterocyclic compounds (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Cancer Treatment and Pharmacology (5 papers), Advanced Synthetic Organic Chemistry (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). The work is most often cited by research in Toxicology (122 citations), Organic Chemistry (954 citations) and Molecular Biology (807 citations). Mark G. Saulnier has collaborated with scholars based in United States and Germany. Frequent co-authors include Gordon W. Gribble, David B. Frennesson, Mukund P. Sibi, Dolatrai M. Vyas, Peter D. Senter, Ingegerd Hellström, George J. Schreiber, Joseph P. Brown, David L. Hirschberg and K E Hellström. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact